Bank of America’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
HWA
DB
Bank of America's CODX Position: Q1 2026 in Review
Bank of America sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 17 shares — an estimated $85 sold.
Bank of America first reported a position in CODX in Q2 2019 and held it in 21 quarters. The position peaked at $2.36M in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- Bank of America reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 17 Co-Diagnostics shares in Q1 2026, an estimated $85.
- Bank of America first reported a position in Co-Diagnostics in Q2 2019 and held it in 21 quarters.
- Bank of America's Co-Diagnostics position peaked at $2.36M in Q2 2020.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.